Coverage
Filings
Orion's collaboration partner Bayer announced U.S. FDA approval for darolutamide, an androgen receptor inhibitor (ARi), for metastatic hormone-sensitive prostate cancer (mHSPC).
| 27 Nov 2007 |
| Appointments into Orion s Executive Management Board as of 1 January 2008 | 15 Nov 2007 |
| Orion sues Sun Pharmaceuticals in the U.S. to enforce a patent for Stalevo® | 13 Nov 2007 |
| 171,347 Orion A-shares converted into B-shares | 7 Nov 2007 |
| Orion Corporation s publication schedules for financial reporting in 2008 | 24 Oct 2007 |
| Orion Group Interim Report 1-9/2007 | 24 Oct 2007 |